From the Department of Medicine, Kidney Research Institute, University of Washington, Seattle (N.B.); Departments of Biostatistics and Epidemiology (C.E.M.) and Medicine (C.-y.H.), University of California, San Francisco; Department of Medicine, Case Western Reserve University, Cleveland, OH (M.R., J.W.); National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD (J.W.K.); Departments of Epidemiology and Biostatistics (A.H.A.), Biostatistics (D.X.), and Medicine (R.R.T., M.C., R.K.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Department of Medicine, University of Chicago, IL (C.M.L.); Kaiser Permanente Northern California Division of Research, Oakland (A.S.G.); Department of Medicine, University of Michigan, Ann Arbor (A.O.); and Department of Medicine, Tulane University, New Orleans, LA (A.A., E.L.).
Hypertension. 2015 Jan;65(1):93-100. doi: 10.1161/HYPERTENSIONAHA.114.04334. Epub 2014 Oct 6.
Studies of hemodialysis patients have shown a U-shaped association between systolic blood pressure (SBP) and mortality. These studies have largely relied on dialysis-unit SBP measures and have not evaluated whether this U-shape also exists in advanced chronic kidney disease, before starting hemodialysis. We determined the association between SBP and mortality at advanced chronic kidney disease and again after initiation of hemodialysis. This was a prospective study of Chronic Renal Insufficiency Cohort participants with advanced chronic kidney disease followed through initiation of hemodialysis. We studied the association between SBP and mortality when participants (1) had an estimated glomerular filtration rate <30 mL/min/1.73 m2 (n=1705), (2) initiated hemodialysis and had dialysis-unit SBP measures (n=403), and (3) initiated hemodialysis and had out-of-dialysis-unit SBP measured at a Chronic Renal Insufficiency Cohort study visit (n=326). Cox models were adjusted for demographics, cardiovascular risk factors, and dialysis parameters. A quadratic term for SBP was included to test for a U-shaped association. At advanced chronic kidney disease, there was no association between SBP and mortality (hazard ratio, 1.02 [95% confidence interval, 0.98-1.07] per every 10 mm Hg increase). Among participants who started hemodialysis, a U-shaped association between dialysis-unit SBP and mortality was observed. In contrast, there was a linear association between out-of-dialysis-unit SBP and mortality (hazard ratio, 1.26 [95% confidence interval, 1.14-1.40] per every 10 mm Hg increase). In conclusion, more efforts should be made to obtain out-of-dialysis-unit SBP, which may merit more consideration as a target for clinical management and in interventional trials.
研究表明,血液透析患者的收缩压(SBP)与死亡率之间呈 U 型关系。这些研究主要依赖于透析单位的 SBP 测量值,并未评估在开始血液透析之前,这种 U 型关系是否也存在于晚期慢性肾脏病患者中。我们确定了晚期慢性肾脏病患者中 SBP 与死亡率之间的关系,然后在开始血液透析后再次进行评估。这是一项对慢性肾功能不全队列参与者的前瞻性研究,这些参与者患有晚期慢性肾脏病,并在开始血液透析后进行随访。当参与者(1)估计肾小球滤过率<30mL/min/1.73m2 时(n=1705),(2)开始血液透析且有透析单位 SBP 测量值时(n=403),以及(3)开始血液透析且在慢性肾功能不全队列研究就诊时有透析单位外 SBP 测量值时(n=326),我们研究了 SBP 与死亡率之间的关系。Cox 模型调整了人口统计学、心血管危险因素和透析参数。SBP 的二次项用于检验 U 型关系。在晚期慢性肾脏病中,SBP 与死亡率之间没有关联(风险比,每增加 10mmHg 为 1.02[95%置信区间,0.98-1.07])。在开始血液透析的参与者中,观察到透析单位 SBP 与死亡率之间呈 U 型关系。相比之下,透析单位外 SBP 与死亡率之间呈线性关系(风险比,每增加 10mmHg 为 1.26[95%置信区间,1.14-1.40])。总之,应该更加努力地获得透析单位外的 SBP,这可能值得更深入地考虑作为临床管理和干预试验的目标。